Report Subject - Medical Affairs - Page 1

Learn More The Impact of Nanomedicine in the Pharma Industry

Can nanomedicines really offer pharma a compelling alternative approach to precision medicines? Delivering accurate diagnosis for clinicians, safer medicines for patients and lower costs through reduced waste and costly...

Compare
Learn More Medical Affairs in Emerging Markets

How can medical affairs capability be enhanced to unlock the Brazilian, Russian, Indian and Chinese pharma markets? The pharma markets of Brazil, Russia, India and China (BRIC) are becoming increasingly complex with...

Compare
Learn More MSL stakeholder engagement: meeting expectations

MSL Stakeholder Engagement–Meeting Expectations In this report, FirstWord identifies practical solutions to the stakeholder engagement challenges faced by medical science liaisons (MSLs) teams in 2017. Discover...

Compare
Learn More Charting MSL Activity and Performance (2017)

A unique survey-based report providing key insights and actionable intelligence about MSL activity and performance. Charting MSL Activity and Performance (2017) distils key findings from one of the most comprehensive...

Compare
Learn More Medical Affairs in Orphan Drugs

Orphan drugs: Is your medical affairs team leading the fray or lagging behind? Traditional commercial models simply don’t work for orphan drugs, not least because the physician and patient populations are so...

Compare
Learn More The Future of Medical Affairs

What are the future opportunities and challenges for medical affairs? As the interface between companies and KOLs, HCPs, payers and patients, medical affairs has grown rapidly in importance. And demands are set to...

Compare
Learn More The Real Value of Medical Affairs

How to push Medical Affairs to the next level of effectiveness Are Medical Affairs (MA) teams doing enough to satisfy doctors? What specific improvements to information and interactions would elevate MA to that...

Compare
Learn More Harnessing the Power of Big Data and Analytics in Medical Affairs

Harness big data insights to improve medical affairs outcomes Medical affairs teams are uniquely placed to apply insights from big data in a range of areas from improving KOL engagement to generate persuasive real world...

Compare
Learn More New KOL Engagement: Building Relationships with the Digital KOL Generation

New Digital KOLs are shaping medical opinion – how do you plan to engage them? Digital KOLs are the new kids on the block and making an impact. Tech savvy medical professionals with something to say are becoming...

Compare
Learn More MSL Metrics: Measuring Success

How to effectively measure MSL performance How can you evaluate MSL activity to ensure effective outcomes? MSLs’ ability to harness KOL feedback provides unique insights to refine clinical, marketing and sales plans...

Compare
Learn More The Role of Medical Affairs in a Successful Commercial Launch

Drive greater product launch success by fully engaging the medical affairs department. Ensure maximum exposure and positive uptake of new therapies by harnessing their talents in scientific interpretation, evidence...

Compare
Learn More Harnessing the Power of Phase IV Observational Studies

Phase IV studies: Pioneering approaches are re-engineering processes, timelines and costs Phase IV is in a state of flux. New digital methods are on trial, there’s an explosion of data sources, and more...

Compare
Learn More Tomorrow’s MSLs

Some experts believe the MSL is poised to become the face of the pharma industry. The primary role of the MSL is to establish and maintain trusted relationships with stakeholders and provide real value. It is this...

Compare
Learn More Innovations in Medical Communications and Information

Today’s medical information and communications teams must look “outside the box” for cost-effective solutions to connecting with an increasingly diverse audience. This report will help you understand...

Compare
Learn More MSL-KOL Engagement: Building Optimal Compliant Relationships

Delivering optimal MSL performance in terms of building strong KOL relationships remains a formidable challenge as regulations and compliance requirements continue to evolve across the US and Europe. More stringent rules...

Compare
Learn More Charting MSL Activity and Performance

A unique survey providing key insights and actionable intelligence. Access expert analysis and data analysis slides in MS PowerPoint and the full data tabulations in MS Excel. Charting MSL Activity and...

Compare
Learn More Building Strong Cross-functional Medical Affairs Teams

Could your Medical Affairs team be better integrated for more effective cross-functional working that drives performance improvement? Building Strong Cross-functional Medical Affairs Teams examines how numerous...

Compare
Learn More Medical Affairs Reputations (EU5): Biosimilar mAbs in Inflammatory Disorders

Based on survey results from 150 rheumatologists, dermatologists, and gastroenterologists in UK, France, Germany, Spain and Italy, Medical Affairs Reputations (EU5): Biosimilar mAbs in Inflammatory Disorders offers...

Compare
Learn More FirstWord Perspectives: Medical affairs teams and payer engagement

In today's pharmaceutical marketplace, medical affairs departments are integral to assuring drugs are being developed in a way that assures access and reimbursement. The FirstWord Perspectives report sponsored by...

Compare
Learn More Medical Affairs Reputations in Oncology (EU5): Oncologists Rate Key Products and Companies

As the cancer drug market continues to face significant challenges in an environment of rising R&D costs, value-based pricing, demands for real world evidence and tougher regulation, the role of Medical Affairs...

Compare

Browse by

FirstWord Medical Affairs Reports